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ABSTRACT 
Background 
Indoor residual spraying (IRS) and long-lasting insecticidal nets (LLINs) are the primary tools 
for malaria prevention in Africa.  It is not known whether reductions in malaria can be sustained 
after IRS is discontinued. The aim of this study was to assess changes in malaria morbidity in a 
historically high transmission area of Uganda where IRS was discontinued after a four-year 
period of effective control followed by a universal LLIN distribution campaign. 
Methods  
Individual-level malaria surveillance data were collected from one outpatient department and one 
inpatient setting in Apac District, Uganda from July 2009 through November 2015. Rounds of 
IRS were delivered approximately every six months from February 2010 through May 2014 
followed by universal LLIN distribution in June 2014. Temporal changes in the malaria test 
positivity rate (TPR) were estimated during and after IRS using interrupted time series analyses, 
controlling for age, rainfall, and autocorrelation.  
Results 
Data include 65,421 outpatient visits and 13,955 pediatric inpatient admissions for which a 
diagnostic test for malaria was performed. In outpatients under five years, baseline TPR was 60-
80% followed by a rapid and then sustained decrease to 15-30%. Over 4-18 months following 
discontinuation of IRS, absolute TPR values increased by an average of 3.29% per month (95% 
CI 2.01-4.57%), returning to baseline levels. Similar trends were seen in outpatients over five 
years of age and pediatric admissions. 
Conclusions  
Discontinuation of IRS in a historically high transmission intensity area was associated with a 
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rapid increase in malaria morbidity to pre-IRS levels.  
 
INTRODUCTION 
Malaria control activities in sub-Saharan Africa have increased approximately twentyfold over 
the last decade resulting in substantial reductions in the burden of malaria [1-3]. Despite these 
advances, the burden of malaria remains high with an estimated 215 million cases and 438,000 
deaths in 2015, of which 88% of cases and 90% of deaths occurred in sub-Saharan Africa [4]. 
The primary interventions for the prevention of malaria include long-lasting insecticidal nets 
(LLINs) and indoor residual spraying of insecticide (IRS). LLINs have been shown to reduce 
malaria morbidity and mortality across a range of epidemiological settings, and the World Health 
Organization (WHO) recommends universal coverage of populations at risk [5, 6]. IRS has also 
been shown to be highly effective, but it is more resource-intensive to implement than 
distribution of LLINs and less than 10% of the population at risk in sub-Saharan Africa is 
currently protected by IRS [4, 7, 8].  
 
Uganda is emblematic of countries with the highest burden of malaria in sub-Saharan Africa, 
where progress in reducing malaria morbidity and mortality has been slowest. LLINs have been 
the primary intervention for the prevention of malaria in Uganda and considerable effort has 
been made to achieving universal LLIN coverage, culminating in a universal LLIN distribution 
campaign conducted from 2013-14. After decades of inactivity, IRS was adopted as a key 
component of Uganda’s malaria control strategy in 2006 with funding from the President’s 
Malaria Initiative. Initial efforts focused on epidemic prone areas in the southwestern part of the 
country. However, in 2008 the IRS program was moved to ten districts in northern Uganda with 
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high transmission intensity. The IRS program in northern Uganda achieved coverage levels 
consistently above 95% and resulted in marked reductions in the burden of malaria [9, 10].  In 
2014, the IRS program was moved from the ten districts in the north, with hopes that gains 
would mainly be sustained following the universal LLIN distribution campaign. 
 
This study utilizes data from an enhanced health facility-based malaria surveillance program 
established in an outpatient and inpatient setting in Apac District, one of the areas in northern 
Uganda where IRS was implemented, and later withdrawn. The study spans a 77-month period 
from July 2009 through November 2015, covering ten rounds of IRS before its discontinuation in 
May 2014, followed by universal distribution of LLINs in June 2014. Our primary objective was 
to evaluate trends in malaria morbidity before, during, and after the implementation of IRS. 
 
METHODS 
Study site and vector control interventions 
The study was conducted in Apac District, an area with historically high malaria transmission 
intensity; in 2002 the entomological inoculation rate was estimated to be over 1,500 infectious 
bites per person per year [11]. Malaria transmission is perennial in this area with peaks following 
the two annual rainy seasons. IRS was first implemented in Apac District in May 2008 with a 
single round of DDT followed by a 2nd round conducted in February 2010 using the pyrethroid 
alpha-cypermethrin. Due to concerns around the emergence of pyrethroid resistance [10], IRS 
was switched to the carbamate bendiocarb in August 2010 with repeated rounds of spraying 
approximately every six months through May 2014. For each round of IRS, the proportion of 
houses sprayed and population protected was over 90% (Table 1). A series of targeted LLIN 
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distribution campaigns were conducted in the area between 2006 and 2010, followed by a 
universal coverage campaign carried out in June 2014 as part of a national program.  According 
to a malaria indicator survey conducted in December 2014, 94% of households reported owning 
at least one LLIN and 77% of persons reported sleeping under an LLIN the prior evening in the 
mid-north region of Uganda, which includes Apac District [12]. 
 
Health facility-based surveillance 
Enhanced malaria surveillance was conducted at one outpatient facility (Aduku Health Center) 
and one inpatient facility including children under 14 years of age (Apac Hospital) as previously 
described (Figure 1) [13, 14]. Briefly, data were collected on demographics, whether malaria was 
suspected (outpatient facility only), whether a laboratory test for malaria was performed, the type 
of laboratory test performed (microscopy or rapid diagnostic test [RDT]), and the laboratory test 
result. Additional training and support was provided to maximize the proportion of patients with 
suspected malaria who underwent diagnostic testing at the outpatient facility and among all 
children admitted at the inpatient facility. For inpatients, additional data were collected on 
disease severity. Patients with severe malaria were defined as having a positive diagnostic test 
and any of the following (based on available data): 1) severe anemia (hemoglobin < 5 g/dL), 2) 
coma, 3) jaundice, or 4) death during hospitalization. Patients with complicated malaria were 
defined as having a positive diagnostic test and any of the following: 1) any of the above criteria 
for severe malaria, 2) inability to breastfeed or drink, 3) convulsions, 4) lethargy, or 5) inability 
to sit up or stand.  
 
Statistical analysis 
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Data were entered using Microsoft Access (Microsoft Corporation, Redmond, Washington, 
USA) and analyzed using STATA (STATA Corp., College Station, TX, USA). The primary 
outcome was the test positivity rate (TPR), defined as the proportion of patients tested for 
malaria (denominator) who tested positive (numerator). The period of observation extended from 
July 2009 through November 2015 for outpatient surveillance and from June 2011 through 
November 2015 for inpatient surveillance. The exposure variable of interest was time, evaluated 
as a categorical variable in relation to the timing of IRS, including a baseline period (July 2009 – 
August 2010), an initial period of effective IRS (September 2010 – February 2011), a sustained 
period of effective IRS (March 2011 – August 2014), which included the first 3 months after the 
last round of IRS was completed, and the 4-18 month period following IRS discontinuation 
(September 2014 – November 2015) when a resurgence of malaria was observed. Temporal 
changes in the monthly TPR over time periods of interest were estimated by interrupted time 
series using ordinary least-squares regression with Newey-West standard errors adjusted for 
estimates of monthly rainfall with a one month lag [15], method of laboratory testing 
(microscopy vs. RDT) and autocorrelation. Outpatient surveillance data were stratified for 
patients under five and five years or older. Among inpatients with laboratory confirmed malaria, 
the probabilities of having complicated malaria, severe malaria, or death with malaria were 
compared between the periods of effective IRS and 4-18 months after IRS was discontinued 
using logistic regression controlling for age, monthly rainfall with a one month lag, and 
autocorrelation by including a quadratic term for the day of observation.  
 
RESULTS  
Characteristics of the study population 
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Over the 77-month observation period, there were 126,260 outpatient encounters of which 53.6% 
were suspected of having malaria. Among patients with suspected malaria, 96.7% underwent 
laboratory testing. Laboratory testing was exclusively based on microscopy until 2012 when 
RDTs became available at the health center. Initially RDT use was low, but increased to 29.4% 
during the 4-18 month period after IRS was discontinued. Following the implementation of IRS 
there was a shift to an older age range among patients suspected and tested for malaria that then 
returned to baseline after IRS was discontinued (Table 2).  
 
Over the 54-month inpatient observation period, 14,595 children were admitted to the hospital of 
which 95.6% underwent diagnostic testing for malaria. Among children tested for malaria, the 
proportion of testing based on RDTs was only 1.6% during the period of effective IRS, 
increasing to 33.0% during the 4-18 month period after IRS was discontinued. The age 
distribution of children admitted to the hospital was similar during the period before and after 
IRS was discontinued (Table 2). 
 
Temporal changes in malaria morbidity in relation to IRS 
For the outpatient surveillance data, the baseline period, which included the one round of IRS 
with alpha-cypermethrin, which was not associated with a significant change in the TPR. During 
this period monthly TPRs ranged from 59-82% in patients under five years and 30-54% for 
patients five years and older (Figure 2). Following the first round of IRS with bendiocarb, there 
was a marked decrease in the TPR. From September 2010 – February 2011, there was an 
absolute decrease in the TPR of 5.84% per month (p<0.0001) reaching 20% in patients under 
five years and 3.06% per month (p=0.001) reaching 14% in patients five years and older (Figure 
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2, Table 3). Rounds of IRS with bendiocarb were repeated approximately every six months 
through May 2014 with a sustained reduction in TPR up to three months following the 
discontinuation of IRS. However, even during this sustained reduction there were unexplained 
short periods where the TPRs “spiked” above what were predicted (e.g. July-November 2013). 
From March 2011 – August 2014, there was an absolute decrease in the TPR of 0.40% per 
month (p=0.002) reaching as low as 10% in patients under five years and 0.41% per month 
(p<0.0001) reaching 4% in patients five years and older (Figure 2, Table 3). A universal LLIN 
distribution campaign was conducted the month following the last round of IRS. During the 4-18 
months after IRS was discontinued there was a significant increase in the TPR, returning to 
baseline levels. From September 2014 – November 2015, there was an absolute increase in the 
TPR of 3.29% per month (p<0.0001) reaching as high as 79% in patients under five years and 
2.78% per month (p<0.0001) reaching 65% in patients five years and older (Figure 2, Table 3). 
Of note, monthly estimates of rainfall with a one month lag time were controlled for in all 
analyses and there was no significant difference in average monthly rainfall in 2015 (mean 
106.1mm) compared to each of the proceeding 4 years (range 97.6-111.6mm, p>0.74 for all pair-
wise comparisons).  
 
Inpatient surveillance began in June 2011, when the 3rd round of IRS with bendiocarb was being 
administered. During the sustained period of effective IRS monthly TPRs among all children 
admitted to the hospital ranged from 17-86%, with an average of 56%. During the 4-18 months 
after IRS was discontinued, there was an absolute increase in the TPR of 5.66% per month 
(p<0.0001) reaching 100% in August 2015 (Figure 2, Table 3). Despite the marked increase in 
TPR following discontinuation of IRS, there was no evidence for worsening of disease severity. 
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Comparing the 4-18 month period after IRS was discontinued to the sustained period of effective 
IRS, the probabilities of having complicated malaria (24.5% vs. 27.2%) and severe malaria 
(1.9% vs. 5.6%) were lower (p<0.0001 for both comparisons) and there was no significant 
change in the probability of death with malaria during hospitalization (0.3% vs. 0.5%, p=0.42).  
 
DISCUSSION 
In a district of Uganda with historically high malaria transmission intensity, the implementation 
of IRS with the carbamate bendiocarb was associated with a rapid decline in the malaria TPR 
among outpatients, followed by a sustained decline over a four-year period. Immediately 
following the discontinuation of IRS, a universal LLIN distribution campaign was conducted 
with the hopes that gains achieved by IRS would be maintained. However, TPRs began to rise 
four months after IRS was discontinued, reaching pre-IRS levels within 18 months. Similar 
trends were seen following discontinuation of IRS among children admitted to the district 
hospital, although there was no evidence of worsening in disease severity.  
 
LLINs and IRS are the most widely used interventions for the prevention of malaria in Africa 
and the WHO recommends universal access to either of these measures [4]. The benefits of 
LLINs have been well-established in randomized controlled trials, with use of LLINs associated 
with reductions in the incidence of malaria of 50% and child mortality of 20% [5]. It has been 
estimated that the incidence of malaria decreased by 40% across sub-Saharan Africa between 
2000 and 2015, and that LLINs were responsible for 68% of cases averted [1]. In Uganda, the 
proportion of households with at least one LLIN increased from 47% to 90% between 2009-
2014, and the average number of LLINs per household increased from 0.8 to 2.5 [12]. 
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Historically, IRS has played a major role in the elimination of malaria in several countries 
outside of Africa and in greatly reducing the burden of malaria in parts of Africa with low or 
seasonal transmission [16, 17]. Although the effectiveness of IRS has been well-established 
through historical and operational evidence, high-quality data from randomized controlled trials 
on the impact of IRS in stable transmission settings is limited [18]. Recent cluster randomized 
trials from Africa comparing IRS combined with LLINs versus either intervention alone have 
provided mixed results [19-21]. Adding IRS to LLINs appears to be most effective in areas 
where LLIN coverage is low, pyrethroid resistance is high, and/or when using IRS with non-
pyrethroid based insecticides [22].  
 
In our study, the benefits of IRS with bendiocarb were clear as evidenced by the dramatic decline 
in malaria morbidity after its initiation followed by an equally dramatic increase shortly after IRS 
was discontinued. The resurgence of malaria occurred despite universal LLIN distribution 
immediately following discontinuation of IRS. These findings raise questions about whether the 
LLINs were used properly, or if insecticide resistance may have limited their effectiveness. The 
recent spread of pyrethroid resistance, the only class of insecticides currently available for 
LLINs, is of concern. The emergence of high-level pyrethroid resistance among the primary 
vectors, An. gambiae s.s. and An. arabiensis, has been reported in Uganda and other parts of 
Africa [23, 24]. Also of concern are putative changes in vector behavior and shifts in the relative 
abundance of vector species, which may increase exposure risk during the early evening hours 
while people are outside of their bed nets and unprotected by LLINs [25]. One reassuring finding 
from our study was the lack of an increased risk of severe or complicated malaria among 
pediatric inpatients during the resurgence of malaria following discontinuation of IRS. However, 
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following the discontinuation of IRS, the TPR among outpatients 5 years and older increased to 
levels higher than those observed before the initiation of effective IRS, suggesting a loss of some 
immunity against uncomplicated malaria.  
 
In the last decade, the WHO has reaffirmed the importance of IRS as a primary intervention for 
reducing malaria transmission in Africa. IRS coverage increased from less than 2% in 2006 to 
11% in 2010. However, the spread of pyrethroid resistance has led many control programs to 
replace pyrethroids with more expensive alternatives such as carbamates or organophosphates, 
leading to downscaling of IRS programs. This has resulted in a reported 53% decrease in the 
number of houses sprayed between years of peak coverage and 2015 across 18 countries in 
Africa supported by the U.S. President’s Malaria Initiative [26]. Historically most malaria 
resurgences have been linked to weakening of control programs. In a systematic review of 75 
malaria resurgence events in 61 countries occurring from the 1930s through the 2000s, 
withdrawal of IRS was a major contributing factor, but this was felt to be primarily due to 
resource constraints or complacency rather than insecticide resistance [27]. In a cross-case study 
review, premature reductions of coverage or withdrawal of IRS were linked to malaria 
resurgence in Cape Verde, Sri Lanka, and Turkey [28]. Contemporary data from Africa on the 
impact of discontinuing IRS is limited given that this has been a recent phenomenon. In the high 
transmission region of Northeastern Zambia, but not in the rest of the country where 
transmission is lower, a resurgence of malaria cases was reported following disruption of IRS 
[29]; in two districts of Tanzania an increase in parasite prevalence was reported following the 
discontinuation of IRS after four years despite distribution of LLINs [26]; and in Benin an 
increase in entomological measures of transmission  was reported following the  discontinuation 
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of IRS after three years despite distribution of LLINs [30]. In contrast, following a 3-year 
experimental program of IRS in South Pare, Tanzania, which ended in 1959, the expected 
resurgence of malaria was delayed for several years which was attributed to changes brought 
about in the original vector mosquito populations and a program to increase the use of 
antimalarial drugs [31]. 
 
Our study had several limitations. Most importantly were the observational study design and the 
lack of a control group. Thus, we are unable to exclude the possibility that factors other than the 
discontinuation of IRS contributed to the resurgence of malaria seen. For example, adherence to 
LLINs was not measured, therefore although LLIN coverage was reportedly high, it is unknown 
whether they were sufficient numbers of LLINs and they were being used properly. In addition, 
the availability of ACTs was not measured and stock outs could have contributed to the 
resurgence.  Another potential limitation was use of the TPR as our outcome measure, which is a 
surrogate measure of malaria incidence and can be influenced by factors such as health facility 
attendance, selection bias for those referred for testing, and the accuracy of laboratory testing. 
Despite these limitations, it is likely that the observed changes in malaria morbidity were related 
to starting and stopping effective IRS given the longitudinal nature of the data, the magnitude of 
changes, and the consistency with which data was collected over an extended period of time.  It 
should also be pointed out that our study area bordered several districts where IRS was not 
implemented (Figure 1), which may have contributed to the rapid resurgence of malaria.  
 
Uganda and other countries in Africa are now facing difficult decisions about the role of IRS 
when demands exceed the availability of resources. Current funding levels are insufficient to 
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achieve full IRS coverage in Uganda and current gains in malaria may not be sustained if control 
measures are withdrawn. In addition, the emergence of pyrethroid resistance has required 
countries to consider alternative classes of insecticide, which can be considerably more 
expensive. There is an urgent need to better define when IRS should be maintained, changed to 
different formulations, or can be safely discontinued or scaled back. This will require effective 
surveillance systems to monitor trends in disease burden and insecticide resistance. In this area 
of historically highly intense transmission the reductions in malaria achieved through effective 
IRS could not be maintained by a LLIN distribution campaign alone. Additional interventions 
are needed to supplement LLINs, ensure LLINs are being used properly and prevent stock outs 
of ACTs when IRS is withdrawn from areas where malaria transmission was historically high. 
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Table 1. Details of indoor residual spraying of insecticide in Apac District 
Formulation of 
insecticide 
Dates of Spraying 
Percentage of 
households sprayed 
Percentage of 
population protected 
DDT 
alpha-cypermethrin 
bendiocarb 
bendiocarb 
bendiocarb 
bendiocarb 
bendiocarb 
bendiocarb 
bendiocarb 
bendiocarb 
bendiocarb 
March – May 2008 
February 23rd – March 31st 2010 
August 23rd – September 21st 2010 
January 5th – January 30th 2011 
May 23rd – June 20th 2011 
November 9th – December 10th 2011 
April 23rd – June 2nd 2012 
October 22nd – November 30th 2012 
April 2nd – May 25th 2013 
November 4th – December 7th 2013 
April 22nd – May 23rd 2014 
92.4% 
99.9% 
99.5% 
99.6% 
97.6% 
93.1% 
90.3% 
92.3% 
97.5% 
92.7% 
92.6% 
91.0% 
99.9% 
99.5% 
99.6% 
97.8% 
94.0% 
90.4% 
93.2% 
96.6% 
93.5% 
91.3% 
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Table 2. Characteristics of study populations from outpatient and inpatient surveillance 
Characteristic 
Time categories 
Baseline 
Initial period of            
effective IRS 
Sustained period of      
effective IRS 
4-18 months after IRS 
discontinued 
Jul 2009 – Aug 2010 Sep 2010 – Feb 2011 Mar 2011 – Aug 2014 Sep 2014 – Nov 2015 
Outpatient surveillance (Aduku Health Center IV) 
Total number of patient encounters a 25,945 8,840 67,575 23,900 
Malaria suspected (% total) 14 718 (56.7%) 5 034 (57.0%) 37 003 (54.8%) 10 879 (45.5%) 
Malaria laboratory testing done (% suspected) 
Microscopy performed (% total tested) b  
Mean age in years if tested (SD) 
Age < 5 years (% total tested) 
14 104 (95.8%) 
14 104 (100%) 
15.6 (18.0) 
6 577 (46.6%) 
4 994 (99.2%) 
4 994 (100%) 
21.3 (19.0) 
1 370 (27.4%) 
36 888 (99.7%) 
35 373 (95.9%) 
19.9 (18.7) 
11 223 (30.4%) 
9 435 (86.7%) 
6 656 (70.6%) 
15.8 (17.6) 
3 430 (36.4%) 
Tested positive for malaria (% total tested) 7 899 (56.0%) 1 643 (32.9%) 8 418 (22.8%) 4 569 (48.4%) 
Inpatient surveillance (Apac Hospital) c 
Total number of children age < 13 years admitted a 
Prior to implementation  
of inpatient surveillance  
8,604 5,991 
Malaria laboratory testing done (% total admitted) 
Microscopy performed (% total tested) b      
Mean age in years if tested (SD) 
8,345 (97.0%) 
8,210 (98.4%) 
3.2 (2.8) 
5,610 (93.6%) 
3,756 (67.0%) 
3.6 (2.9) 
Tested positive for parasites (% total tested) 4,650 (55.7%) 4,683 (83.5%) 
Complicated malaria (% laboratory confirmed cases) 1,264 (27.2%) 1,146 (24.5%) 
Severe malaria (% laboratory confirmed cases) 261 (5.6%) 90 (1.9%) 
Death with malaria (% laboratory confirmed cases) 42 (0.5%) 17 (0.3%) 
a Excludes patients with no age recorded 
b RDT performed if microscopy not done 
c Inpatient surveillance began June 2011 
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Table 3. Temporal changes in malaria test positivity rates in relation to IRS 
Patient population Age group 
Estimated average monthly change in absolute value of TPR 
Initial period of effective IRS Sustained period of effective IRS 4-18 months after IRS discontinued 
Sep 2010 – Feb 2011 Mar 2011 – Aug 2014 Sep 2014 – Nov 2015 
Δ TPR (95% CI) a p-value Δ TPR (95% CI) a p-value Δ TPR (95% CI) a p-value 
Outpatient surveillance 
< 5 years - 5.84% (-7.44 to -4.24%) <0.001 - 0.40% (-0.64 to -0.16%) 0.002 3.29% (2.01 to 4.57%) <0.001 
> 5 years - 3.06% (-4.89 to -1.24%) 0.001 - 0.41% (-0.61 to -0.21%) <0.001 2.78% (2.01 to 3.54%) <0.001 
Inpatient surveillance  b < 13 years N/A N/A  5.66% (3.22 to 8.10%) <0.001 
a Adjusted for rainfall with a one month lag and proportion of laboratory testing based on microscopy vs. RDT 
b Inpatient surveillance began June 2011 
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Figure Legends 
Figure 1.  
Map of Uganda with study district (solid red) and other nine districts where IRS was 
discontinued (red dots). Expanded view of study district with location of outpatient (Aduku HC 
IV) and inpatient (Apac Hospital) health facilities were surveillance data collected.  
 
Figure 2.  
Temporal changes in malaria test positivity rates in relation to IRS. Vertical dashed lines 
separate the study period into the following 4 categories: a baseline period (July 2009 – August 
2010), an initial period of effective IRS (September 2010 – February 2011), a sustained period of 
effective IRS (March 2011 – August 2014), which included the first 3 months after the last round 
of IRS was completed, and the 4-18 month period following IRS discontinuation (September 
2014 – November 2015) when a resurgence of malaria was observed. Pink bars show the timing 
of indoor residual spraying (IRS) with a single round of alpha-cypermethrin, yellow bars the 
timing of IRS with nine rounds of bendiocarb, and blue bars the mass deployment of long-lasting 
insecticidal nets. 
 
 
 
